-
1.发明申请Apoptotic entities for use in treatment of neurodegenerative and other neurological disorders 审中-公开用于治疗神经变性和其他神经障碍的凋亡实体公开(公告)号：US20070087010A1
公开(公告)日：2007-04-19
申请号：US11583986
申请日：2006-10-17
申请人： Anthony Bolton , Arkady Mandel , Daniel Sauder
发明人： Anthony Bolton , Arkady Mandel , Daniel Sauder
CPC分类号： A61K35/17
摘要： Treatment and/or prophylaxis, in mammalian patients, of neurodegenerative and other neurological medical disorders is effected by administering to the patient effective amounts of apoptotic bodies and/or apoptotic cells, preferably those derived from the patient's own white blood cells, e.g. by extracorporeal treatment of the patient's blood cells to induce apoptosis and administration of the apoptotic bodies and/or cells so formed to the patient.
摘要翻译： 通过向患者施用有效量的凋亡小体和/或凋亡细胞，优选来源于患者自己的白细胞的那些细胞，例如，在哺乳动物患者中治疗和/或预防神经退行性疾病和其它神经病学疾病。 通过体外治疗患者的血液细胞以诱导凋亡和向患者形成的凋亡小体和/或细胞的施用。
-
2.发明申请公开(公告)号：US20070298020A1
公开(公告)日：2007-12-27
申请号：US11831261
申请日：2007-07-31
申请人： Anthony Bolton , Arkady Mandel , Daniel Sauder
发明人： Anthony Bolton , Arkady Mandel , Daniel Sauder
摘要： Treatment and/or prophylaxis of endothelial dysfunction-related disorders in mammalian patients is effected by administering to the patient effective amounts of apoptotic bodies and/or apoptotic cells.
摘要翻译： 通过向患者施用有效量的凋亡小体和/或凋亡细胞来实现哺乳动物患者内皮功能障碍相关疾病的治疗和/或预防。
-
3.发明申请公开(公告)号：US20080063631A1
公开(公告)日：2008-03-13
申请号：US11855092
申请日：2007-09-13
申请人： Anthony Bolton , Arkady Mandel , Daniel Sauder
发明人： Anthony Bolton , Arkady Mandel , Daniel Sauder
IPC分类号： A61K38/00
CPC分类号： A61K35/17
摘要： Treatment and/or prophylaxis of endothelial dysfunction-related disorders in mammalian patients is effected by administering to the patient effective amounts of apoptotic bodies and/or apoptotic cells.
摘要翻译： 通过向患者施用有效量的凋亡小体和/或凋亡细胞来实现哺乳动物患者内皮功能障碍相关疾病的治疗和/或预防。
-
4.发明申请APOPTOTIC ENTITIES FOR USE IN TREATMENT OF NEURODEGENERATIVE AND OTHER NEUROLOGICAL DISORDERS 审中-公开用于治疗神经损伤和其他神经疾病的药物公开(公告)号：US20080131416A1
公开(公告)日：2008-06-05
申请号：US11927094
申请日：2007-10-29
申请人： Anthony E. Bolton , Arkady Mandel , Daniel Sauder
发明人： Anthony E. Bolton , Arkady Mandel , Daniel Sauder
CPC分类号： A61K35/17
摘要： Treatment and/or prophylaxis, in mammalian patients, of neurodegenerative and other neurological medical disorders is effected by administering to the patient effective amounts of apoptotic bodies and/or apoptotic cells, preferably those derived from the patient's own white blood cells, e.g. by extracorporeal treatment of the patient's blood cells to induce apoptosis and administration of the apoptotic bodies and/or cells so formed to the patient.
摘要翻译： 通过向患者施用有效量的凋亡小体和/或凋亡细胞，优选来源于患者自己的白细胞的那些细胞，例如，在哺乳动物患者中治疗和/或预防神经退行性疾病和其它神经病学疾病。 通过体外治疗患者的血液细胞以诱导凋亡和向患者形成的凋亡小体和/或细胞的施用。
-
5.发明授权公开(公告)号：US07132285B2
公开(公告)日：2006-11-07
申请号：US09871146
申请日：2001-05-25
申请人： Anthony E. Bolton , Arkady Mandel , Daniel Sauder
发明人： Anthony E. Bolton , Arkady Mandel , Daniel Sauder
CPC分类号： A61K35/17
摘要： Treatment and/or prophylaxis, in mammalian patients, of neurodegenerative and other neurological medical disorders is effected by administering to the patient effective amounts of apoptotic bodies and/or apoptotic cells, preferably those derived from the patient's own white blood cells, e.g. by extracorporeal treatment of the patient's blood cells to induce apoptosis and administration of the apoptotic bodies and/or cells so formed to the patient.
-
-
-
-
搜索结果
5 条记录 (耗时 0.016 秒)
